Vimarsana
Biggest News Aggregation in the World

Page 14 - Research Misconduct News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Misconduct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Misconduct Today - Breaking & Trending Today

Talking leadership 16: Sigbritt Karlsson on struggling to get women into STEM - Vimarsana News

Talking leadership 16: Sigbritt Karlsson on struggling to get women into STEM

The president of KTH Royal Institute of Technology discusses the fallout of a scientific scandal and immigration rules in Sweden

DOJ Drops China Initiative Acknowledging Civil Rights Concerns | Cohen Seglias Pallas Greenhall & Furman PC - Vimarsana News

DOJ Drops China Initiative Acknowledging Civil Rights Concerns | Cohen Seglias Pallas Greenhall & Furman PC

After two years of misguided prosecutions targeting Chinese scientists, the U.S. Department of Justice (DOJ) announced it is discontinuing its “China Initiative,” effective immediately....

Why Did a Federal Watchdog Make Just Three Findings of Misconduct? - Vimarsana News

Why Did a Federal Watchdog Make Just Three Findings of Misconduct?

In 2021, ORI made just 3 findings of misconduct, a drop from 10 — roughly the average over the past 15 years — in 2020. Such cases can take years.

ORIC welcomes Linnea Ista to director position - Vimarsana News

ORIC welcomes Linnea Ista to director position

The Office of Research Integrity and Compliance (ORIC) is pleased to announce Dr. Linnea Ista as the new Director of Conflict of Interest in Research and Research Misconduct Programs. In this position, Ista will manage, coordinate, and operate the...

Source: unm.edu
Enzymatica AB: Enzymatica comments on wrongful wording in Dagens Medicin - Vimarsana News

Enzymatica AB: Enzymatica comments on wrongful wording in Dagens Medicin

STOCKHOLM, Jan. 12, 2022 /PRNewswire/ -- The headline and introduction of an article today on the webpage of the Swedish magazine Dagens Medicin wrongfully claim that a study on ColdZyme has